The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The launch coincides with IBS Awareness Month in April
The innovation is particularly suited for bone and cartilage repair
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Subscribe To Our Newsletter & Stay Updated
